Published in J Acquir Immune Defic Syndr on December 01, 2006
Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet (2011) 5.34
Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol (2011) 1.58
A proposal for quality standards for measuring medication adherence in research. AIDS Behav (2013) 1.51
Improving the self-report of HIV antiretroviral medication adherence: is the glass half full or half empty? Curr HIV/AIDS Rep (2009) 1.49
MACH14: a multi-site collaboration on ART adherence among 14 institutions. AIDS Behav (2013) 1.14
Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naïve, HIV patients. HIV Clin Trials (2011) 1.10
Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women. Antimicrob Agents Chemother (2009) 1.01
Calibration of self-reported oral health to clinically determined standards. Community Dent Oral Epidemiol (2010) 0.97
Psychosocial Syndemics are Additively Associated with Worse ART Adherence in HIV-Infected Individuals. AIDS Behav (2015) 0.95
Improving Adherence to Care Among "Hard to Reach" HIV-Infected Patients in Argentina. AIDS Behav (2016) 0.77
Low-Cost Method to Monitor Patient Adherence to HIV Antiretroviral Therapy Using Multiplex Cathepsin Zymography. Mol Biotechnol (2016) 0.75
Medication Adherence and HIV Symptom Distress in Relation to Panic Disorder Among HIV-Positive Adults Managing Opioid Dependence. Cognit Ther Res (2014) 0.75
Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care (2007) 12.71
International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis (2011) 12.29
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Class-sparing regimens for initial treatment of HIV-1 infection. N Engl J Med (2008) 8.50
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol (2007) 6.24
Trends in antimicrobial drug development: implications for the future. Clin Infect Dis (2004) 5.23
Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med (2008) 5.13
The role of the bifactor model in resolving dimensionality issues in health outcomes measures. Qual Life Res (2007) 4.61
Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy. J Infect Dis (2008) 4.61
A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med (2002) 4.49
Psychometric properties of the Consumer Assessment of Health Plans Study (CAHPS) 2.0 adult core survey. Health Serv Res (2003) 4.24
Race/ethnicity, language, and patients' assessments of care in Medicaid managed care. Health Serv Res (2003) 4.19
Representativeness of the Patient-Reported Outcomes Measurement Information System Internet panel. J Clin Epidemiol (2010) 4.18
Quality of care is associated with survival in vulnerable older patients. Ann Intern Med (2005) 4.05
Relationship between number of medical conditions and quality of care. N Engl J Med (2007) 3.78
Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health (2008) 3.68
Multimorbidity is associated with better quality of care among vulnerable elders. Med Care (2007) 3.63
US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Med Care (2007) 3.56
Regulatory role of SGT1 in early R gene-mediated plant defenses. Science (2002) 3.43
Men who have sex with men and women: a unique risk group for HIV transmission on North Carolina College campuses. Sex Transm Dis (2006) 3.34
The quality of pharmacologic care for vulnerable older patients. Ann Intern Med (2004) 3.34
Physician communication when prescribing new medications. Arch Intern Med (2006) 3.27
Do older adults expect to age successfully? The association between expectations regarding aging and beliefs regarding healthcare seeking among older adults. J Am Geriatr Soc (2002) 3.26
The opportunity cost of futile treatment in the ICU*. Crit Care Med (2014) 3.21
Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems. Int J Epidemiol (2008) 3.14
Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis (2007) 3.12
Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol (2005) 2.98
Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep (2005) 2.97
Sex with older partners is associated with primary HIV infection among men who have sex with men in North Carolina. J Acquir Immune Defic Syndr (2010) 2.89
Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection. N Engl J Med (2003) 2.81
Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med (2012) 2.81
Patients' global ratings of their health care are not associated with the technical quality of their care. Ann Intern Med (2006) 2.68
Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. J Acquir Immune Defic Syndr (2006) 2.65
Half standard deviation estimate of the minimally important difference in HRQOL scores? Expert Rev Pharmacoecon Outcomes Res (2004) 2.58
Sexual behaviours of HIV-seropositive men and women following release from prison. Int J STD AIDS (2006) 2.58
Estimating clinically significant differences in quality of life outcomes. Qual Life Res (2005) 2.55
Efficiency of static and computer adaptive short forms compared to full-length measures of depressive symptoms. Qual Life Res (2009) 2.55
Patterns of unit and item nonresponse in the CAHPS Hospital Survey. Health Serv Res (2005) 2.49
Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes (2006) 2.48
Development and psychometric assessment of a multidimensional measure of internalized HIV stigma in a sample of HIV-positive adults. AIDS Behav (2008) 2.39
Linguistic disparities in health care access and health status among older adults. J Gen Intern Med (2006) 2.35
Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.I. Health Qual Life Outcomes (2007) 2.34
Determinants of medical expenditures in the last 6 months of life. Ann Intern Med (2011) 2.33
Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA. J Infect Dis (2006) 2.26
Specialty training and specialization among physicians who treat HIV/AIDS in the United States. J Gen Intern Med (2002) 2.21
Methodological challenges associated with patient responses to follow-up longitudinal surveys regarding quality of care. Health Serv Res (2003) 2.21
Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev (2008) 2.20
Impact of cancer on health-related quality of life of older Americans. J Natl Cancer Inst (2009) 2.20
Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol (2010) 2.19
Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective. J Clin Oncol (2011) 2.16
HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. PLoS One (2009) 2.16
Exploratory factor analyses of the CAHPS Hospital Pilot Survey responses across and within medical, surgical, and obstetric services. Health Serv Res (2005) 2.15
Clinically validated genotype analysis: guiding principles and statistical concerns. Antivir Ther (2004) 2.14
Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options. J Hepatol (2012) 2.14
Restructuring primary care practices to manage geriatric syndromes: the ACOVE-2 intervention. J Am Geriatr Soc (2003) 2.13
Serious infections caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2010) 2.13
Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample. Qual Life Res (2009) 2.10
Psychometric properties of a group-level Consumer Assessment of Health Plans Study (CAHPS) instrument. Med Care (2005) 2.09
Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro. J Infect Dis (2008) 2.08
Therapeutic drug monitoring in HIV infection: current status and future directions. AIDS (2002) 2.08
Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology (2005) 2.07
What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health (2007) 2.06
Effect of a multidisciplinary intervention on communication and collaboration among physicians and nurses. Am J Crit Care (2005) 2.06
Severity of visual field loss and health-related quality of life. Am J Ophthalmol (2007) 2.05
Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study. Clin Infect Dis (2003) 2.05
Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among african american men with HIV. J Acquir Immune Defic Syndr (2010) 2.05
Is the influence of social desirability on patients' self-reported adherence overrated? J Acquir Immune Defic Syndr (2004) 2.03
Patients' preferences for technical versus interpersonal quality when selecting a primary care physician. Health Serv Res (2005) 2.01
Mode of administration is important in US national estimates of health-related quality of life. Med Care (2007) 2.00
Arabidopsis RPP4 is a member of the RPP5 multigene family of TIR-NB-LRR genes and confers downy mildew resistance through multiple signalling components. Plant J (2002) 1.99
Arabidopsis RAR1 exerts rate-limiting control of R gene-mediated defenses against multiple pathogens. Plant Cell (2002) 1.99
Quality indicators for geriatric emergency care. Acad Emerg Med (2009) 1.98
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res (2013) 1.96
The unexpected movement of the HIV epidemic in the Southeastern United States: transmission among college students. J Acquir Immune Defic Syndr (2005) 1.93
Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res (2009) 1.93
Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials. AIDS (2009) 1.93
Specialties differ in which aspects of doctor communication predict overall physician ratings. J Gen Intern Med (2013) 1.89
The frequency and cost of treatment perceived to be futile in critical care. JAMA Intern Med (2013) 1.86
Health plan effects on patient assessments of Medicaid managed care among racial/ethnic minorities. J Gen Intern Med (2004) 1.86
Review of the literature on survey instruments used to collect data on hospital patients' perceptions of care. Health Serv Res (2005) 1.85
How well do clinicians estimate patients' adherence to combination antiretroviral therapy? J Gen Intern Med (2002) 1.84